Minneapolis-based biotech startup Vergent Bioscience Inc. last week announced it received $8.7 million in a round of financing led by…
Read More
YOU MAY HAVE MISSED
Create a free account, or log in.
Gain access to read this article, plus limited free content.
You must be logged in to post a comment.